Inventor
GARCIA-BLANCO MARIANO A
US17 patents
⚠️ This page may combine multiple inventors who share the name “GARCIA-BLANCO MARIANO A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
6 patentsUS11118186B2Sep 14, 2021
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
UNIV TEXAS2 citations70
US10961581B2Mar 30, 2021
Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)
UNIV TEXAS4 citations65
US12359204B2Jul 15, 2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
UNIV TEXAS0 citations59
US12247206B2Mar 11, 2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
UNIV TEXAS0 citations59
US11807853B2Nov 7, 2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
UNIV TEXAS0 citations59
US12203138B2Jan 21, 2025
Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)
UNIV TEXAS0 citations55
UNIV DUKE
4 patentsUS9845481B2Dec 19, 2017
Synthetic regulation of gene expression
UNIV DUKE6 citations81
US10161939B2Dec 25, 2018
Method of isolating circulating tumor cells
UNIV DUKE10 citations79
US9284575B2Mar 15, 2016
Synthetic regulation of gene expression
UNIV DUKE3 citations70
US11567081B2Jan 31, 2023
Method of isolating circulating tumor cells
UNIV DUKE1 citations58
VIRXSYS CORP
4 patentsUS7968334B2Jun 28, 2011
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
VIRXSYS CORP4 citations60
US7871795B2Jan 18, 2011
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
VIRXSYS CORP2 citations60
US7879321B2Feb 1, 2011
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
VIRXSYS CORP2 citations59
US8053232B2Nov 8, 2011
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
VIRXSYS CORP4 citations57